Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $203.09 million as of January 9, 2026. Its market cap has increased by 211.01% in one year.

• Market Cap: 203.09M
• Enterprise Value: 317.62M
• 1-Year Change: 211.01%
• Ranking: #3828
• Category: Micro-Cap
• Stock Price: $3.15

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $203.09M, an increase of 90.16%. That is a compound annual growth rate of 2.92%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	206.30M	-23.08%
Dec 31, 2025	268.20M	231.11%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%
Sep 10, 2003	106.80M	-

View and export this data all the way back to 2003. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	992.16B
Johnson & Johnson	499.90B
AbbVie	412.54B
UnitedHealth Group	309.53B
AstraZeneca	297.23B
Novartis AG	273.49B
Merck & Co.	269.55B
Novo Nordisk	254.60B